bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-techmaterials. The co...
Currenta offers services for the chemical industry including utility supply, waste management,           infrastructure, s...
Research and development expenses                                2,746   3,053            11,2Dividend per Bayer AG share ...
Bayer is a global enterprise with core competencies in the fields of health care
Upcoming SlideShare
Loading in …5
×

Bayer is a global enterprise with core competencies in the fields of health care

1,022 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,022
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Bayer is a global enterprise with core competencies in the fields of health care

  1. 1. bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-techmaterials. The company’s products and services are designed to benefit people and improve their qualityof life. At the same time Bayer creates value through innovation, growth and high earning power.The Group is committed to the principles of sustainable development and to its role as a socially and ethicallyresponsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equalrank. In fiscal 2010, Bayer employed 111,400 people and had sales of €35.1 billion. Capital expendituresamounted to €1.6 billion, R&D expenses to €3.1 billion.OrganizationBayer AG defines common values, goals and strategies for the entire Group. The three subgroups and threeservice companies operate independently, led by the management holding company. The Corporate Centersupports the Group Management Board in its task of strategic leadership.Bayer HealthCareBayer CropScienceBayer MaterialScienceBayer Business ServicesBayer Technology ServicesCurrentaOrganization chart with management structure and fields of activityDownload 113 KBBusiness operations are the responsibility of the subgroups: Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products. » more Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control. » more Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses. » moreCentral service functions are combined into three service companies: Bayer Business Services is the Bayer Group’s international competence center for it-based services. » more Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver. » more
  2. 2. Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training. » moreCorporate GovernanceDual governance system with the following governance bodies:Board of Management: four members, Chairman: Dr. Marijn DekkersSupervisory Board: 20 members, Chairman: Dr. Manfred SchneiderProductsThe Bayer Group markets some 5,000 products. Best-sellers include: in the health care field: Betaferon™/Betaseron™, Yasmin™/YAZ™/Yasminelle™, Kogenate™ in the nutrition field: Confidor™/ Gaucho™/Admire™/Merit™, Flint™/Stratego™/Sphere™/Nativo™ in the field of high-tech materials: Makrolon™, Bayblend™, Desmodur™, Desmophen™LocationsBayer is represented around the world by about 300 companies*. Global headquarters are in Leverkusen,Germany.* fully consolidated subsidiaries (as of Dec. 31, 2010)WorkforceOn December 31, 2010, the Bayer Group had 111.400 employees worldwide (2009: 111.000). In Germany wehad 36.200 employees, who made up 32,5 percent of the Group workforce.Bayer stock included in nearly all the major share indices traded on all German stock exchanges dividend per share: EUR 1.50Bayer Group Key DataBayer Group 2009 2010 Change € million € million %Sales 31,168 35,088 12,6EBITDA1 5,815 6,286 8,1EBITDA before special items 6,472 7,101 9,7EBIT2 3,006 2,730 -9,2EBIT before special items 3,772 4,452 18,0Income before income taxes 1,870 1,721 -8,0Net income 1,359 1,301 -4,3Earnings per share (in €)3 1.70 1.57 -7,6Gross cash flow4 4,658 4,771 2,4Net cash flow5 5,375 5,773 7,4Capital expenditures as per segment table 1,669 1,621 -2,9
  3. 3. Research and development expenses 2,746 3,053 11,2Dividend per Bayer AG share (€) 1.40 1.50 7,1figures restated1-5 for definition see footnotes to Bayer Group Key Data tableSales by Segment, (2009 in parentheses)Members of the Board of Management held offi ces as members of the supervisory board or a comparablesupervising body of the corporations listed (as at July 1, 2011):Dr. Marijn Dekkers(born September 22, 1957)Chairman (effective October 1, 2010)Member of the Board of Management effective January 1, 2010, appointed until December 31, 2014Werner Baumann(born October 6, 1962)Member of the Board of Management effective January 1, 2010, appointed until December 31, 2012 Bayer Business Services GmbH (Chairman) (effective May 1, 2010) Bayer CropScience AG (Chairman) (effective May 1, 2010)Prof. Dr. Wolfgang Plischke(born September 15, 1951)Member of the Board of Management effective March 1, 2006, appointed until February 28, 2014 Bayer MaterialScience AG (Chairman) Bayer Technology Services GmbH (Chairman) Bayer Innovation GmbH, Shareholders’ Committee (Chairman) Bayer Real Estate GmbH, Shareholders’ Committee (Chairman)Dr. Richard Pott(born May 11, 1953)Member of the Board of Management effective May 1, 2002, appointed until April 30, 2012Labor Director Bayer Chemicals AG (Chairman) Bayer HealthCare AG (Chairman) Bayer Pharma AG (Chairman) Currenta Geschäftsführungs-GmbH (Chairman) Bayer Innovation GmbH, Shareholders’ Committee

×